• Skip to primary navigation
  • Skip to main content
  • Skip to footer
Invitae | Genelex

Invitae | Genelex

Pharmacogenetics Makes Precision Medicine Possible

  • For Patients
    • Conditions
    • Affected Drugs
    • What is PGx?
    • Resources
    • FAQs
  • For Providers
    • Conditions
    • Resources
    • Order Testing Supplies
  • Test Menu
  • Clinical Trials
  • About
    • Lab Accreditations
    • Genelex Team
    • Contact Us
  • Log In

jjurik

Genetic Guidance of Warfarin Dosing Shows Promise from Heartwire – Sue Hughes

Genelex Blog Genetic Guidance of Warfarin Dosing Shows Promise from Heartwire - Sue Hughes November 7, 2007 (Orlando, FL) – Using genetic tests as well as clinical factors improved the accuracy and efficiency of warfarin dose initiation, but the primary end point of a reduction in out-of-

Metabolic Polymorphisms and Cancer Susceptibility

Genelex Blog Metabolic Polymorphisms and Cancer Susceptibility The vast majority of cancers arise as a consequence of exposure to environmental agents that are toxic or mutagenic. In response to this, all higher organisms have evolved complex mechanisms by which they can protect themselves

Contributions of CYP2C9/CYP2C19 genotypes and drug interaction to the phenytoin treatment in the Korean epileptic patients in the clinical setting

Genelex Blog Contributions of CYP2C9/CYP2C19 genotypes and drug interaction to the phenytoin treatment in the Korean epileptic patients in the clinical setting We examined the contribution of CYP2C9 and CYP2C19 genotypes and drug interactions to the phenytoin metabolism among 97 Korean

Drug interactions and pharmacogenetic reactions are the basis for chloroquine and mefloquine-induced psychosis

Genelex Blog Drug interactions and pharmacogenetic reactions are the basis for chloroquine and mefloquine-induced psychosis BACKGROUND - Chloroquine and mefloquine used for prophylaxis and treatment of malaria sometimes causes severe mental status changes,including psychosis, through

The influence of NSAIDs on coumarin sensitivity in patients with CYP2C9 polymorphism after total hip replacement surgery

Genelex Blog The influence of NSAIDs on coumarin sensitivity in patients with CYP2C9 polymorphism after total hip replacement surgery OBJECTIVE - To determine the influence of NSAIDs on the international normalized ratio (INR) in patients with cytochrome P450 (CYP)-2C9 enzyme variants

  • « Go to Previous Page
  • Go to page 1
  • Interim pages omitted …
  • Go to page 31
  • Go to page 32
  • Go to page 33

Footer

CONTACT US

(800) 837-8362
info@genelex.com

3101 Western Ave.
Suite 100
Seattle, WA 98121

HELPFUL INFORMATION

What is PGx?
Test Menu
Conditions
Affected Drugs
FAQs
References

ABOUT GENELEX

Blog
News
Genelex Team
Lab Accreditations
Contact Us
Privacy Practices
Privacy Policy

  • Facebook
  • LinkedIn
  • RSS
  • Twitter
  • YouTube

KEEP IN TOUCH

Stay in the loop with news and updates from Genelex and be among the first to know when new tests become available.